SLU-PP-332 20mg

SLU-PP-332 is a research-grade oral small molecule agonist of ERR (estrogen-related receptor) proteins, particularly ERRα, designed for experimental studies on mitochondrial biogenesis, exercise mimetic effects, and metabolic endurance in muscle and energy homeostasis models. This compound activates PGC-1α coactivator pathways to explore enhanced fat oxidation, oxidative capacity, and performance adaptations without physical training.

Core Benefits

• Boosts mitochondrial density and function in skeletal muscle fibers, with preclinical research indicating improved endurance, fatty acid utilization, and resistance to fatigue in sedentary models.

• Enhances metabolic flexibility by upregulating type I fiber characteristics, supporting investigations into obesity reversal, insulin sensitivity, and aerobic capacity.

• Demonstrates potential for whole-body energy expenditure elevation, positioning it as a tool for studying sarcopenia prevention and training augmentation in aging paradigms.

For research purposes only. Not intended for human consumption.